Healthcare Co. Wants Share of $17.5B Addiction Treatment Industry
Source: Jason McCarthy  (7/14/22)
One healthcare co. is currently rated a Buy and is making a push for a share of the $17.5-billion addiction treatment industry after a recent study showed its psychedelic-assisted psychotherapy treatment showed a significant decrease in alcohol use, noted a Maxim Group equity research report. More >

Green Tech's 'Bugs' to Find Gold in Ecuador
Source: Streetwise Reports  (7/14/22)
This green tech company will use its rock-eating bugs to process gold from mining production in Ecuador—and possibly somewhere near you. More >

Biopharma Co. Posts 17% BMI Reduction in Ph. 2 Trial
Source: Streetwise Reports  (7/14/22)
Shares of Rhythm Pharmaceuticals Inc. rose by over 30% after the company posted positive interim results from its Phase 2 clinical study of setmelanotide in hypothalamic obesity. The data shows that after 16 weeks of treatment with setmelanotide, patients experienced a 17.2% mean reduction in BMI and a mean weight loss of 15.8%. More >

Gold Junior Poised for Breakout
Source: Clive Maund   (7/14/22)
Technical Analyst Clive Maund explains why this junior gold explorer in Papua New Guinea that is gearing up to go far is a Buy in his book. More >

Analyst Sees 'Attractive Long-Term Economics' for Healthcare Co.
Source: Andrew Partheniou  (7/13/22)
One healthcare company with upcoming catalysts wants to take a share of the CA$6-billion alcoholism treatment market with its proprietary psychedelic-assisted psychotherapy treatments. More >

Milestones Reached at British Columbia Gold Asset
  (7/13/22)
At this project in a historical mining district, extensive mine preparations were completed, then mining and processing of placer gold commenced, which "could be a major catalyst for the stock." More >

Updated PFS May Pave Way to Partnership
Source: Streetwise Reports  (7/13/22)
A simpler open-pit only mine plan for Seabridge Gold’s massive KSM copper-gold project in northern B.C. could attract a joint-venture partner. But it might not be the company you think. More >

EV Maker Signs Agreement With Walmart for Up to 10,000 LDVs
Source: Streetwise Reports  (7/12/22)
Shares of Canoo Inc. traded 57% higher after the company reported that Walmart has contracted to purchase 4,500 of its electric Lifestyle Delivery Vehicles for use in its growing e-commerce business. The agreement includes an option for 5,500 additional units. More >

Three Analysts Like Healthcare Co.'s Upside
Source: Streetwise Reports  (7/11/22)
It is difficult to get three people to agree on anything, let alone three investment analysts. But that is precisely the case with one junior biotech company that has shown in a clinical trial that its ketamine-assisted therapy for alcohol use disorder (AUD) is three times more effective than the current standard of care. More >

Pharma Looks To Improve Potential Psychedelic Stroke Drug
Source: Streetwise Reports  (7/11/22)
Can a psychedelic compound help you heal after a stroke? This biopharmaceutical company hopes it can and plans to start Phase 1 trials this September. More >

EV Co. Secures Huge No. of Orders for Off-Road Vehicle
Source: Streetwise Reports  (7/11/22)
Shares of Volcon Inc. traded 47% after the all-electric powersports company reported that over the course of just 14 days it received thousands of pre-orders for its class-leading 125 hp Stag EV. The orders are expected to provide the firm with an additional $70 million in revenue. More >

Gold Co. Positioned To Be Next Tier One Asset in Ontario
Source: Maurice Jackson  (7/11/22)
Expert Maurice Jackson sits down with the CEO of Goldshore Resources Inc., Brett Richards to go over the latest updates with the company. With just one year under its belt, Goldshore Resources is already positioning itself to become the next tier one asset in Ontario. The flagship Moss Lake Property has a historical resource with significant expansion potential and is currently undergoing a 100,000-meter drill program, with impressive initial assay results. More >

Altius Invests in Lara Exploration
Source: Adrian Day  (7/11/22)
Expert Adrian Day reviews updates at some of his favorite companies, including most recently the news between Altius Minerals Corp. and Lara Exploration Ltd.'s relationship. More >

Oil Price Problem? Expert Says Look to 2011
Source: Michael J. Ballanger  (7/11/22)
Expert Michael Ballanger reviews this week's updates in the oil and gas sector, specifically his view on the U.S. government's handling of sanctions against Russia and how that will impact the economy. More >

New Drug Is Shown to Help Stopped or Reduced Bile Flow
  (7/10/22)
Albireo Pharma Inc.'s positive Phase 3 trial results indicate the medication would afford patients clinical and quality of life benefits, noted an H.C. Wainwright & Co. report. More >

New DMD Drug Yields 'Compelling' Data
  (7/9/22)
A statistical reanalysis of trial results from Sarepta Therapeutics Inc. shows improved patient function, noted an Oppenheimer report. More >

Amended Agreement to Benefit Two Biotech Firms
  (7/8/22)
In the new arrangement between Beam Therapeutics Inc. and Verve Therapeutics Inc. each of the companies grants the other an exclusive license, one to a base editing target, the other to a gene delivery technology, noted a Wedbush report. More >

Today’s Bear Market Lowers the Risk on New Gold Discoveries
Source: Matt Badiali  (7/8/22)
Independent financial analyst Matt Badiali reviews the current bear market in junior mining stocks, profiling Vizsla Silver, Arizona Sonoran Copper Company, and Cross River Ventures Corp. to tell you which stock's risks are worth the reward. More >

Is KRL the Next K92?
Source: Streetwise Reports  (7/7/22)
This morning, newsletter writer Bob Moriarty, after not writing about a junior mining stock since early June, published an opinion piece on KRL Resources — and came out with a Buy recommendation on the junior. More >

Co. Makes Financing Deals Around Two of Its Approved Drugs
  (7/7/22)
The agreements include milestone payments based on future revenue from sales of the biopharma Blueprint Medicines Corp.'s therapies, noted a Wedbush report. More >

Mine Operator Locks In High Copper Prices for 2023
Source: Streetwise Reports  (7/7/22)
Taseko Mines Ltd.'s shares traded 10% higher after the mine developer and operator reported that last month prior to the recent downturn in raw copper prices it had secured contracts for H1/23 for an additional 30Mlb Cu at prices ranging from $3.75-4.20/lb More >

Wealth Minerals Raises Cash, Drills Lithium Play in Chile
Source: Streetwise Reports  (7/6/22)
As money dries up for a lot of mineral exploration, it seems that investors will still write checks for lithium plays. One junior with two lithium projects in Chile recently raised over $3 million — and the investors approached the company. More >

Copper's Future Still Bright in Colombia, Analyst Says
Source: Streetwise Reports  (7/6/22)
The leftist president-elect of Colombia has promised to halt new gas and oil development. But the government has highlighted the importance of finding new forms of energy for the green transition, and one analyst says copper will play a big role in that future. More >

Strong Data Suggest FDA Will Approve New Lymphoma Drug
  (7/6/22)
A green light is expected for the treatment after its developers submit a biologics license application for it, planned for H2/22, noted an H.C. Wainwright & Co. report. More >

Gold Terra Hits Campbell Shear at Depth for the First Time
Source: The Critical Investor  (7/6/22)
The Critical Investor discusses the first results of deep drilling aimed at the Campbell Shear with CEO Gerald Panneton. More >